证券代码：603262 证券简称：技源集团 公告编号：2025-026 技源集团股份有限公司 关于使用闲置募集资金进行现金管理赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 技源集团股份有限公司（以下简称"公司"）于2025年8月12日召开第二届董事 会第四次会议和第二届监事会第三次会议审议通过了《关于使用部分闲置募集资金 进行现金管理的议案》，同意公司在不影响募集资金投资项目建设的情况下，使用 总额不超过45,000万元（含本数）的闲置募集资金进行现金管理，用于购买安全性 高、流动性好、低风险、稳健型的保本型理财产品（单项产品投资期限最长不超过 12个月，包括但不限于结构性存款、协定存款、通知存款、大额存单、收益凭证等)。 使用期限为自公司董事会审议通过之日起12个月内。在前述额度和期限范围内，资 金可循环滚动使用。详见公司于2025年8月13日披露的《关于使用部分闲置募集资金 进行现金管理的公告》（2025-007）。 | 受托方 | 产品名称 | 金额 | 预期年 化收益 | 起息日 | 产品到期 | 本次赎 ...

Core Points - The company has completed the registration capital change, cancellation of the supervisory board, and amendments to the Articles of Association as approved in the board meetings held on August 29 and September 23, 2025 [1] - The company has obtained a new business license from the Wuxi Market Supervision Administration, reflecting the updated registration information [1] Company Information - Company Name: 技源集团股份有限公司 (Tech Source Group Co., Ltd.) - Unified Social Credit Code: 91320281741344724C - Type: Joint-stock company (with investment from Hong Kong, Macau, and Taiwan, listed) - Legal Representative: 龙玲 (Long Ling) - Registered Capital: 400.01 million RMB - Establishment Date: September 17, 2002 - Address: No. 2, Jinxiu Road, Jiangyin Lingang Economic Development Zone, Jiangsu [1] Business Scope - Production of various products including chondroitin sulfate, β-hydroxy-β-methylbutyrate calcium, and others - Processing and packaging services for disinfectants (excluding hazardous materials) - Quality inspection technical services - Research, development, and sales of health-related products and food [1]

证券日报网讯 11月27日晚间，技源集团发布公告称，技源集团股份有限公司（以下简称"公司"）于 2025年8月29日、2025年9月23日分别召开了第二届董事会第五次会议、2025年第一次临时股东大会，审 议通过了《关于变更公司注册资本、取消监事会并修订的议案》。公司于近日完成上述事项的工商变更 登记手续，并取得了无锡市市场监督管理局换发的《营业执照》。 （编辑 楚丽君） ...

证券代码：603262 证券简称：技源集团 公告编号：2025-025 技源集团股份有限公司 关于完成工商变更登记的公告 法定代表人：龙玲 注册资本：40001 万元人民币 成立日期：2002 年 9 月 17 日 住所：江苏江阴临港经济开发区锦绣路 2 号 经营范围：生产硫酸软骨素、β--羟基--β--甲基丁酸钙、依普黄酮、联二硫 胺素、L--谷氨酰胺、7--酮基 DHEA、氨基葡萄糖盐酸盐，食品的生产、加工，消 毒剂（不含危险品）的包装服务，提供质检技术服务；银杏黄酮、茶多酚、大豆 异黄酮、硫酸软骨素、氨基葡萄糖、依普黄酮、丙酮酸盐、肌酸、β--羟基--β-- 甲基丁酸钙、联二硫胺素、L--谷氨酰胺、7--酮基 DHEA、氨基葡萄糖盐酸盐的研 究、开发、销售；预包装食品、散装食品、乳制品（含婴幼儿配方乳粉）的销售； 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 技源集团股份有限公司（以下简称"公司"）于 2025 年 8 月 29 日、2025 年 9 月 23 日分别召开了第二届董事会第五次会议、2025 年第一次临时 ...

（文章来源：证券日报） 证券日报网讯技源集团11月25日在互动平台回答投资者提问时表示，截至2025年10月31日，公司的股东 人数为25700户。 ...

Core Viewpoint - The company has approved the use of idle raised funds for cash management, allowing for investment in low-risk financial products to enhance liquidity and returns [1]. Group 1: Fund Management Approval - The company’s board approved the use of up to 450 million yuan of idle raised funds for cash management, ensuring it does not affect the construction of investment projects [1]. - The approved financial products include structured deposits, agreed deposits, notice deposits, large certificates of deposit, and income certificates, with a maximum investment term of 12 months [1]. Group 2: Fund Utilization and Redemption - On August 21, 2025, the company utilized 125 million yuan of idle funds to purchase structured deposits from Ningbo Bank [2]. - The structured deposit matured on November 21, 2025, and the company successfully redeemed the principal of 125 million yuan along with a return of 630,136.99 yuan, which met expectations [2].

证券代码：603262 证券简称：技源集团 公告编号：2025-024 技源集团股份有限公司董事会 技源集团股份有限公司 2025年11月24日 关于使用闲置募集资金进行现金管理赎回的公告 | 受托方 | 产品名 | 金额 | 预期年化收 | 起息日 | 产品到期 | 本次赎 回（万元 | 本次收益 | | --- | --- | --- | --- | --- | --- | --- | --- | | 称 | | （万元） | 益率 | | 日 | ） | （元） | | 宁波银 | 结构性 存款 | 12,500 | 1.00%-2.00% | 2025.8.21 | 2025.11.21 | 12,500 | 630,136.99 | | 行 | | | | | | | | | 特此公告。 | | | | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 技源集团股份有限公司（以下简称"公司"）于2025年8月12日召开第二届董事 会第四次会议和第二届监事会第三次会议审议通过了《关于使用部分闲置募集资金 ...

Core Insights - The company, 技源集团, is a leading global supplier of HMB (β-Hydroxy β-Methylbutyrate), a crucial nutrient for muscle health, with a market share of approximately 65.80% in 2022 [1] - HMB is recognized for its unique ability to both increase muscle protein synthesis and reduce muscle protein breakdown, making it suitable for various sectors including sports nutrition, elderly health, weight management, and post-operative recovery [1] - The global demand for HMB is projected to grow, with estimated production volumes of 1,662.43 tons in 2023 and 1,758.50 tons in 2024, indicating a market share of around 52.27% and 53.34% for the company respectively [1] Financial Performance - For the first half of 2025, the company reported a revenue of 560 million yuan, representing a year-on-year growth of 15.65% [2] - Revenue from nutritional raw materials reached 390 million yuan, up 18.94%, while formulation product sales amounted to 170 million yuan, growing by 8.75% [2] - HMB sales specifically generated 158 million yuan, reflecting a growth of 3.75% [2] Market Development - The company maintains stable partnerships with major clients like Abbott while actively exploring new market opportunities and customer bases [2] - New HMB products are being developed for various applications, including adult milk powder for healthy aging and differentiated products for sports nutrition [2] - The company is also pursuing opportunities in pet nutrition and animal feed, collaborating with a large international agricultural enterprise [2]

Group 1 - The core viewpoint of the news is that 技源集团 (TechSource Group) experienced a decline in stock price and a net outflow in financing on November 17, with a trading volume of 36.29 million yuan and a financing balance of 65.33 million yuan, which represents 5.77% of its market capitalization [1] - As of September 30, the number of shareholders for TechSource Group decreased by 56.80% to 26,900, while the average circulating shares per person increased by 131.47% to 1,444 shares [2] - For the period from January to September 2025, TechSource Group reported a revenue of 797 million yuan, reflecting a year-on-year growth of 7.58%, while the net profit attributable to shareholders decreased by 14.72% to 117 million yuan [2] Group 2 - The main business of TechSource Group includes the research, innovation, and industrialization of dietary nutritional supplements, with revenue composition as follows: nutritional raw materials 34.70%, formulations 15.24%, and various specific nutritional raw materials and formulations contributing to the total [1]

Group 1 - The company approved the use of idle raised funds for cash management, with a total amount not exceeding 450 million yuan, to invest in low-risk financial products [1] - The investment products include structured deposits, agreement deposits, notice deposits, large certificates of deposit, and income certificates, with a maximum investment period of 12 months [1] - The funds can be used in a rolling manner within the approved amount and time frame [1] Group 2 - On August 15, 2025, the company used 100 million yuan of idle raised funds to purchase structured deposits from Shanghai Pudong Development Bank [2] - The structured deposit matured on November 14, 2025, and the company successfully redeemed the principal of 100 million yuan along with a return of 487,500 yuan, which met expectations [2]